Dysglycaemia in the critically ill - significance and management (Q38078016)

28 August 2017

1 reference

title

Dysglycaemia in the critically ill - significance and management (English)

1 reference

28 August 2017

A M Deane

1

1 reference

28 August 2017

M Horowitz

series ordinal

2

1 reference

28 August 2017

publication date

25 February 2013

1 reference

Diabetes, Obesity and Metabolism

28 August 2017

published in

1 reference

28 August 2017

volume

15

1 reference

28 August 2017

issue

9

1 reference

28 August 2017

page(s)

792-801

1 reference

Clinical practice. Glycemic control in the ICU.

28 August 2017

cites work

1 reference

Management of diabetes and hyperglycemia in hospitals

21 January 2018

1 reference

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis

21 January 2018

1 reference

Blood glucose concentration and outcome of critical illness: the impact of diabetes

21 January 2018

1 reference

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study.

21 January 2018

1 reference

A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes

21 January 2018

1 reference

21 January 2018

Stress hyperglycaemia

1 reference

The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes

21 January 2018

1 reference

Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness

21 January 2018

1 reference

HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.

21 January 2018

1 reference

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

Hypoglycemia and risk of death in critically ill patients

21 January 2018

1 reference

The impact of early hypoglycemia and blood glucose variability on outcome in critical illness

21 January 2018

1 reference

Severe hypoglycemia in critically ill patients: risk factors and outcomes

21 January 2018

1 reference

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

21 January 2018

1 reference

Glycemic variability in critical illness and the end of Chapter 1.

21 January 2018

1 reference

Variability of blood glucose concentration and short-term mortality in critically ill patients

21 January 2018

1 reference

Glucose variability and mortality in patients with sepsis.

21 January 2018

1 reference

Glycemic variability: a strong independent predictor of mortality in critically ill patients

21 January 2018

1 reference

Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality

21 January 2018

1 reference

Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot study

21 January 2018

1 reference

The metrics of glycaemic control in critical care

21 January 2018

1 reference

Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data

21 January 2018

1 reference

Alterations in fuel metabolism in critical illness: hyperglycaemia

21 January 2018

1 reference

Role of insulin and glucagon in the response of glucose and alanine kinetics in burn-injured patients

21 January 2018

1 reference

The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients

21 January 2018

1 reference

APACHE II: a severity of disease classification system

21 January 2018

1 reference

Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis

21 January 2018

1 reference

Insulin-treated diabetes is not associated with increased mortality in critically ill patients

21 January 2018

1 reference

Diabetes mellitus does not adversely affect outcomes from a critical illness.

21 January 2018

1 reference

Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus

21 January 2018

1 reference

Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis

21 January 2018

1 reference

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

Hypoglycemia and outcome in critically ill patients

21 January 2018

1 reference

Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction

21 January 2018

1 reference

Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial

21 January 2018

1 reference

Glycemic variability and mortality in critically ill patients: the impact of diabetes

21 January 2018

1 reference

Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change

21 January 2018

1 reference

Towards closed-loop glycaemic control

21 January 2018

1 reference

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

What do we know about the secretion and degradation of incretin hormones?

21 January 2018

1 reference

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

21 January 2018

1 reference

The potential role of glucagon-like peptide-1 or its analogues in enhancing glycaemic control in critically ill adult patients

21 January 2018

1 reference

The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

21 January 2018

1 reference

Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia

21 January 2018

1 reference

Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes

21 January 2018

1 reference

The therapeutic potential of a venomous lizard: the use of glucagon-like peptide-1 analogues in the critically ill

21 January 2018

1 reference

Gastric inhibitory polypeptide: the neglected incretin revisited

21 January 2018

1 reference

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

21 January 2018

1 reference

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

21 January 2018

1 reference

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

21 January 2018

1 reference

GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes

21 January 2018

1 reference

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis

21 January 2018

1 reference

Early versus Late Parenteral Nutrition in Critically Ill Adults

21 January 2018

1 reference

Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units: Benefit Versus Harm

21 January 2018

1 reference

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12078

1 reference

28 August 2017

1 reference